Clinical Trial Detail

NCT ID NCT02847559
Title Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

meningioma

Therapies

Bevacizumab

Age Groups: senior adult

No variant requirements are available.